NAKA PE Ratio & Valuation,Is NAKA Overvalued

NAKA Relative Valuation

NAKA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NAKA is overvalued; if below, it's undervalued.

Historical Valuation

Kindly MD Inc (NAKA) is now in the Fair zone, suggesting that its current forward PS ratio of 4.54 is considered Fairly compared with the five-year average of 13.43. The fair price of Kindly MD Inc (NAKA) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：0.45

Fair

-2.03

-69.93

EV/EBITDA

Kindly MD Inc. (NAKA) has a current EV/EBITDA of -69.93. The 5-year average EV/EBITDA is 396.39. The thresholds are as follows: Strongly Undervalued below -1753.26, Undervalued between -1753.26 and -678.44, Fairly Valued between 1471.21 and -678.44, Overvalued between 1471.21 and 2546.03, and Strongly Overvalued above 2546.03. The current Forward EV/EBITDA of -69.93 falls within the Historic Trend Line -Fairly Valued range.

-44.44

EV/EBIT

Kindly MD Inc. (NAKA) has a current EV/EBIT of -44.44. The 5-year average EV/EBIT is 814.69. The thresholds are as follows: Strongly Undervalued below -3784.63, Undervalued between -3784.63 and -1484.97, Fairly Valued between 3114.34 and -1484.97, Overvalued between 3114.34 and 5414.00, and Strongly Overvalued above 5414.00. The current Forward EV/EBIT of -44.44 falls within the Historic Trend Line -Fairly Valued range.

4.54

Kindly MD Inc. (NAKA) has a current PS of 4.54. The 5-year average PS is 10.26. The thresholds are as follows: Strongly Undervalued below -30.52, Undervalued between -30.52 and -10.13, Fairly Valued between 30.65 and -10.13, Overvalued between 30.65 and 51.04, and Strongly Overvalued above 51.04. The current Forward PS of 4.54 falls within the Historic Trend Line -Fairly Valued range.

6.29

P/OCF

Kindly MD Inc. (NAKA) has a current P/OCF of 6.29. The 5-year average P/OCF is 26.67. The thresholds are as follows: Strongly Undervalued below -92.81, Undervalued between -92.81 and -33.07, Fairly Valued between 86.41 and -33.07, Overvalued between 86.41 and 146.15, and Strongly Overvalued above 146.15. The current Forward P/OCF of 6.29 falls within the Historic Trend Line -Fairly Valued range.

6.29

P/FCF

Kindly MD Inc. (NAKA) has a current P/FCF of 6.29. The 5-year average P/FCF is 26.70. The thresholds are as follows: Strongly Undervalued below -92.91, Undervalued between -92.91 and -33.10, Fairly Valued between 86.50 and -33.10, Overvalued between 86.50 and 146.30, and Strongly Overvalued above 146.30. The current Forward P/FCF of 6.29 falls within the Historic Trend Line -Fairly Valued range.

Kindly MD Inc (NAKA) has a current Price-to-Book (P/B) ratio of 0.37. Compared to its 3-year average P/B ratio of 16.60 , the current P/B ratio is approximately -97.80% higher. Relative to its 5-year average P/B ratio of 16.60, the current P/B ratio is about -97.80% higher. Kindly MD Inc (NAKA) has a Forward Free Cash Flow (FCF) yield of approximately -9.38%. Compared to its 3-year average FCF yield of -6.43%, the current FCF yield is approximately 45.92% lower. Relative to its 5-year average FCF yield of -6.43% , the current FCF yield is about 45.92% lower.

0.37

P/B

Median3y

16.60

Median5y

16.60

-9.38

FCF Yield

Median3y

-6.43

Median5y

-6.43

Competitors Valuation Multiple

The average P/S ratio for NAKA's competitors is 29.94, providing a benchmark for relative valuation. Kindly MD Inc Corp (NAKA) exhibits a P/S ratio of 4.54, which is -84.84% above the industry average. Given its robust revenue growth of -40.08%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of NAKA decreased by 97.92% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -156.54 to -22.16K.

The secondary factor is the Revenue Growth, contributed -40.08%to the performance.

Overall, the performance of NAKA in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-40.08%

647.87K → 388.21K

Revenue Growth

14057.56%

-156.54 → -22.16K

Margin Expansion

-14115.40%

0.00 → -0.25

P/E Change

-97.92%

22.60 → 0.47

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Kindly MD Inc (NAKA) currently overvalued or undervalued?

What is Kindly MD Inc (NAKA) fair value?

NAKA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Kindly MD Inc (NAKA) is between to according to relative valuation methord.

How does NAKA's valuation metrics compare to the industry average?

What is the current P/B ratio for Kindly MD Inc (NAKA) as of Jan 08 2026?

As of Jan 08 2026, Kindly MD Inc (NAKA) has a P/B ratio of 0.37. This indicates that the market values NAKA at 0.37 times its book value.

What is the current FCF Yield for Kindly MD Inc (NAKA) as of Jan 08 2026?

As of Jan 08 2026, Kindly MD Inc (NAKA) has a FCF Yield of -9.38%. This means that for every dollar of Kindly MD Inc’s market capitalization, the company generates -9.38 cents in free cash flow.

What is the current Forward P/E ratio for Kindly MD Inc (NAKA) as of Jan 08 2026?

As of Jan 08 2026, Kindly MD Inc (NAKA) has a Forward P/E ratio of -2.03. This means the market is willing to pay $-2.03 for every dollar of Kindly MD Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Kindly MD Inc (NAKA) as of Jan 08 2026?

As of Jan 08 2026, Kindly MD Inc (NAKA) has a Forward P/S ratio of 4.54. This means the market is valuing NAKA at $4.54 for every dollar of expected revenue over the next 12 months.

NAKA Valuation